Rare Diseases × Sarcoma × Clear all
NCT02834013 2026-03-18

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
818 enrolled
NCT01793168 2025-05-29

CoRDS

Sanford Health

Recruiting
20,000 enrolled